EULAR guidelines for fibromyalgia have been updated for the first time in a decade but their focus does not reflect a novel understanding of the disease or a new approach to management.
Lead author of the guidelines Professor Gary Macfarlane from the University of Aberdeen said the new guidelines differed in the level of evidence to support them.
Since 2007 there had been a plethora of studies and the new guidelines were based on 107 systematic reviews and meta-analysis.
“They allow us to move from recommendations which are based on ‘expert’ opinion to those which are ‘evidence based’” he told the audience.
The guidelines focus on the prompt diagnosis and comprehensive assessment of patients and remain centred on a non-pharmacological approach to management, specifically exercise.
“If there is a lack of effect therapy should be individualised according to patient need, which may include pharmacological therapy” Professor Macfarlane said.
If symptoms are characterised by pain-related depression and anxiety the guidelines recommend cognitive behavioural therapy (CBT).